[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-396200-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-396200-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","escap-practice-guidance-for-autism-a-summary-of-evidence-based-recommendations-for-diagnosis-and-treatment","ESCAP practice guidance for autism - a summary of evidence-based recommendations for diagnosis and treatment","","Across Europe, growing awareness of autism spectrum disorder (ASD) highlights its persistence throughout life and its status as a heterogeneous neurodevelopmental condition. Although service provision for autistic people and families varies widely, many European countries offer limited support. The ESCAP ASD Working Party, endorsed by the ESCAP Board in 2019, presents evidence-based guidance focused on detecting, diagnosing, and treating autism across ages, using reviews and existing international guidelines.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/escap-practice-guidance-for-autism-a-summary-of-evidence-based-recommendations-for-diagnosis-and-treatment/396200/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/escap-practice-guidance-for-autism-a-summary-of-evidence-based-recommendations-for-diagnosis-and-treatment/396200.png","ImageObject",300,407,{"name":42,"@type":43},"awa","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-26",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main purpose of the ESCAP practice guidance on autism?","Question",{"text":63,"@type":64},"The document aims to disseminate information that can be adopted in regular clinical practice across Europe and to provide clinicians and educators with evidence-based advice on core and minimum standards for assessment and treatment of autistic people of all ages.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were recommendations developed for the practice guidance?",{"text":68,"@type":64},"The process involved appointing an ESCAP ASD working party, reviewing drafts through ESCAP Clinical Division members, and incorporating revisions before endorsement by the ESCAP Board in 2019. A narrative review of English-language evidence on diagnostic assessments and treatments across the lifespan was conducted from June 2018 to April 2020.",{"name":70,"@type":61,"acceptedAnswer":71},"What diagnostic framework does the document use for ASD criteria?",{"text":72,"@type":64},"The document uses DSM-5 criteria and explains that “autism” is used as shorthand for autism spectrum disorder as defined in the DSM-5. It lists requirements for deficits in social communication/interaction and restricted, repetitive patterns of behavior.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},396200,1790718436,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Research & Report",30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":99,"preview_page_count":4},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","European Child & Adolescent Psychiatry [https://doi.org/10.1007/s00787-020-01587-4](https://doi.org/10.1007/s00787-020-01587-4)  \nESCAP practice guidance for autism: a summary of evidence‑based recommendations for diagnosis and treatment  \nJoaquin Fuentes1 · Amaia Hervás2 · Patricia Howlin3 · (ESCAP ASD Working Party)  \nReceived: 23 July 2019 / Accepted: 24 June 2020 © The Author(s) 2020  \nAbstract  \nAcross Europe, there is increased awareness of the frequency and importance of autism spectrum disorder (ASD), which is now recognised not only as a childhood disorder but as a heterogeneous, neurodevelopmental condition that persists throughout life. Services for individuals with autism and their families vary widely, but in most European countries, provision is limited. In 2018, European Society of Child and Adolescent Psychiatry (ESCAP) identified the need for a Practice Guidance document that would help to improve knowledge and practice, especially for individuals in underserviced areas. The present document, prepared by the ASD Working Party and endorsed by the ESCAP Board on October 3, 2019, summarises current information on autism and focuses on ways of detecting, diagnosing, and treating this condition.  \nKeywords Autism · Diagnosis and treatment · ESCAP review  \nProcess and methods for the development of this practice guidance  \nThe first author (J.F.) was designated, in July 2015, as the ESCAP Autism Field Advisor, with the brief of considering the setting up of European autism guidelines. In June 2018, the Board appointed three experts (J.F. , A.H. and P.H.) asthe ESCAP ASD working party and instructed them to produce the Practice Guidance document. The resulting draft document was reviewed by members of the ESCAP Clinical Division and, following some revisions, was subsequently endorsed by Board of ESCAP on 03/10/2019 .  \nElectronic supplementary material The online version of this article ([https://doi.org/10.1007/s00787-020-01587-4](https://doi.org/10.1007/s00787-020-01587-4)) contains supplementary material, which is available to authorized users.  \n* Joaquin Fuentes [fuentes.j@telefonica.net](fuentes.j@telefonica.net)  \n1 Child and Adolescent Psychiatrists, Policlínica Gipuzkoa Research Consultant, GAUTENA Autism Society, Paseo de Miramón 174, 20016 San Sebastián, Spain  \n2 Child and Adolescent Psychiatrists, University Hospital MutuaTerrassa, AGAUR Clinical and Genetic Research Group IGAIN, Barcelona, Spain  \n3 Emeritus Professor of Clinical Child Psychology, Institute of Psychiatry, Psychology and Neuroscience, King’s College, London, UK  \nThe primary goal of this document is to disseminate information that can be adopted for use in regular clinical practice across Europe and to present clinicians and educators with evidence-based advice on core and minimum standards for good practice in the assessment and treatment of autistic people of all ages. It was not possible, within the scope of the present article, to complete systematic reviews and/or meta-analyses of all the issues related to autism covered here. Consequently, the aim is not to make specific recommendations for the use of particular interventions or assessment methodologies but rather to provide general guidance, based on a combination of information from randomised and non-randomised trials, expert opinion, and other existing international guidelines.  \nDuring the period from June 2018 to April 2020, a narrative review of papers published in English on evidencebased diagnostic assessments and treatments across the lifecycle of people with autism 1 was conducted. The emphasis was on European clinical research, but also included key international contributions. We focussed on clinical research updates published during the 3 years prior to submitting the final draft of this document and, in addition, we consulted existing clinical guidelines from Spain [1, 2], United  \n1 In this document, we use a combination of “person first” language (e.g.,“people wit","cbCaiaZVPqaPj1WY","https://ap.wps.com/l/cbCaiaZVPqaPj1WY","pdf",966620,24,"English","# Abstract\n# Process and methods for the development of this practice guidance\n# Core goals of the document\n# Narrative review period and evidence sources\n# Diagnostic criteria—DSM-5\n## ASD diagnostic criteria\n# Diagnostic classification systems DSM-5","[{\"question\":\"What is the main purpose of the ESCAP practice guidance on autism?\",\"answer\":\"The document aims to disseminate information that can be adopted in regular clinical practice across Europe and to provide clinicians and educators with evidence-based advice on core and minimum standards for assessment and treatment of autistic people of all ages.\"},{\"question\":\"How were recommendations developed for the practice guidance?\",\"answer\":\"The process involved appointing an ESCAP ASD working party, reviewing drafts through ESCAP Clinical Division members, and incorporating revisions before endorsement by the ESCAP Board in 2019. A narrative review of English-language evidence on diagnostic assessments and treatments across the lifespan was conducted from June 2018 to April 2020.\"},{\"question\":\"What diagnostic framework does the document use for ASD criteria?\",\"answer\":\"The document uses DSM-5 criteria and explains that “autism” is used as shorthand for autism spectrum disorder as defined in the DSM-5. It lists requirements for deficits in social communication/interaction and restricted, repetitive patterns of behavior.\"}]","ESCAP practice guidance for autism - a summary of evidence-based recommendations for diagnosis and treatment | PDF",1790434451]